Dorota Ziółkowska, Mirosław Szeligowski

Leki onkologiczne w rejestrach centralnych

Oncology drugs in central registers. Procedure of implementing European legislation on new drug registration into Polish law has been shortly described with a special attention to centralized procedures. Groups of innovative drugs undergoing central procedure has been listed and term of a "new substance" has been cleared. Oncology drugs undergoing central registration has been listed in two table. The first table contain cytostatic and cytotoxic substances, hormone agonists, cytokines and immunomodulators and immunosuppressive drugs. The second table lists drugs used in supportive treatment of cancer.